Morning Trend | MEDSCI falls near platform support, will the oversold rebound window come?

MEDSCI (2415.HK) experienced a round of weak downward movement yesterday, approaching the low point support of the phase platform during the session. The pharmaceutical and health sector has seen a lack of significant news this week, and the industry's defensive attributes have not shown obvious amplification, with short-term funds exhibiting a prominent wait-and-see tendency. There are no highlights in the company's related announcements, and most major players have chosen to observe the situation. Trading volume has shrunk, with slight support at low levels, but there are no signs of a significant rebound. The MACD continues to decline, which technical analysts usually view as a signal of continued weakness. However, once the sector experiences policy catalysts or sudden positive news from leading companies, pharmaceutical stocks often have a rapid recovery capability. Community discussions have shifted focus to whether there can be a time-based stop-loss action in the platform area, and the short-term window may expand with news-related fluctuations. If the platform support is breached, the oversold market may continue to extend, and it is recommended to dynamically track sector rotation sentiment and pay attention to sudden policy catalysts